Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 7/20 | 0.75 |
| ▸ | P2RX3 | P56373 | 6/20 | 0.75 |
| ▸ | P2RX2 | Q9UBL9 | 6/20 | 0.75 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.75 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.75 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.75 |
| ▸ | SRC | P12931 | 2/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.72 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.70 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.70 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.70 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.70 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.70 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.66 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.66 |
| ▸ | LDHA | P00338 | 1/20 | 0.66 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.66 |
| ▸ | FBP1 | P09467 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1331755 | 1.00 | P2RY1 (0.75) | P2RY1P2RX3P2RX2P2RY2P2RX4 | |
| SCHEMBL163281 | 1.00 | P2RY1 (0.75) | P2RY1P2RX3P2RX2P2RY2P2RX4 | |
| SCHEMBL163282 | 1.00 | P2RY1 (0.75) | P2RY1P2RX3P2RX2P2RY2P2RX4 | |
| SCHEMBL1331745 | 1.00 | P2RY1 (0.75) | P2RY1P2RX3P2RX2P2RY2P2RX4 | |
| SCHEMBL5365040 | 1.00 | P2RY1 (0.75) | P2RY1P2RX3P2RX2P2RY2P2RX4 | |
| SCHEMBL27837591 | 0.99 | P2RY1 (0.74) | P2RY1P2RX3P2RX2P2RY2P2RX4 | |
| SCHEMBL28009685 | 0.99 | P2RY1 (0.74) | P2RY1P2RX3P2RX2P2RY2P2RX4 | |
| Pyrophosphoric Acid SCHEMBL27579246 | 0.99 | P2RY1 (0.74) | P2RY1P2RX3P2RX2P2RY2P2RX4 | |
| SCHEMBL29134096 | 0.99 | P2RY1 (0.74) | P2RY1P2RX3P2RX2P2RY2P2RX4 | |
| SCHEMBL23711717 | 0.99 | P2RX3 (0.74) | P2RY1P2RX3P2RX2P2RY2P2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120989190-A | Preparation method for preparing inosine 5' -triphosphate through enzyme catalysis | 上海日冠生物科技有限公司 | 2025-11-21 | — | — | CN | disclosed |
| CN-120989190-A | Preparation method for preparing inosine 5' -triphosphate through enzyme catalysis | 上海日冠生物科技有限公司 | 2025-11-21 | — | — | CN | disclosed |
| CN-120944989-A | Preparation method of inosine 5 '-triphosphate and inosine 5' -triphosphate | 上海日冠生物科技有限公司 | 2025-11-14 | — | — | CN | disclosed |
| CN-120944989-A | Preparation method of inosine 5 '-triphosphate and inosine 5' -triphosphate | 上海日冠生物科技有限公司 | 2025-11-14 | — | — | CN | disclosed |
| US-20250213580-A1 | Improved Thiopurine Formulation and Treatment Methods | DOUGLAS PHARMACEUTICALS LTD (NZ) | 2025-07-03 | — | — | US | disclosed |
| CN-119799819-A | Preparation method for preparing inosine-5' -diphosphate by enzyme catalysis | 上海日冠生物科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| EP-4499105-A1 | IMPROVED THIOPURINE FORMULATION AND TREATMENT METHODS | Douglas Pharmaceuticals Limited (NZ) | 2025-02-05 | — | — | EP | disclosed |
| CN-118946361-A | Improved thiopurine formulations and methods of treatment | 道格拉斯制药有限公司 | 2024-11-12 | — | — | CN | disclosed |
| EP-4437125-A1 | RNA AND DNA ANALYSIS USING ENGINEERED SURFACES | Alida Biosciences, Inc. (US) | 2024-10-02 | — | — | EP | disclosed |
| CN-118660973-A | RNA and DNA analysis Using engineered surfaces | 阿丽达生物科学公司 | 2024-09-17 | — | — | CN | disclosed |
| CN-113474644-B | Electrode and electrochemical measurement system | 日东电工株式会社 | 2024-04-12 | — | — | CN | disclosed |
| CN-117795096-A | Methods, compositions and kits for preparing sequencing libraries | 吉复生物科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117042767-A | Methods of treating cancer using STING agonists | 丹娜法伯癌症研究院 | 2023-11-10 | — | — | CN | disclosed |
| WO-2023182895-A1 | IMPROVED THIOPURINE FORMULATION AND TREATMENT METHODS | DOUGLAS PHARMACEUTICALS LTD (NZ) | 2023-09-28 | — | — | WO | disclosed |
| CN-111511754-B | 2'3' cyclic dinucleotides with phosphonate bonds of activated STING adaptor protein | 捷克共和国有机化学与生物化学研究所 | 2023-09-12 | — | — | CN | disclosed |
| WO-2023097295-A1 | RNA AND DNA ANALYSIS USING ENGINEERED SURFACES | ALIDA BIOSCIENCES, INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| EP-4093882-A1 | VIRUS DETECTION | Sense Biodetection Limited (GB) | 2022-11-30 | — | — | EP | disclosed |
| CN-115003828-A | Virus detection | 圣斯生物检测有限公司 | 2022-09-02 | — | — | CN | disclosed |